期刊文献+

人类肺癌组织中COX-2的表达及其与K-ras和Mcl-1表达的关系 被引量:4

The Expression of COX-2 in Human Lung Cancer and its Relationship with Expression of K-ras and Mcl-1
下载PDF
导出
摘要 背景与目的环氧化酶-2(Cyclooxygenase-2,COX-2)是花生四烯酸代谢限速酶的一个亚型,已发现COX-2与肿瘤的发生、发展和转移有关。本文旨在探讨肺癌组织中COX-2表达的临床病理学意义,及其与K-ras和Mcl-1表达的相互关系。方法应用免疫组织化学染色及图像分析系统检测COX-2、K-ras和Mcl-1在101例肺癌及7例正常肺组织中的表达。结果COX-2在非小细胞肺癌组织中高表达(P<0.05),以腺癌表达最高;在周围型肺癌(P<0.05)及中晚期肺癌组织中高表达(P<0.05);并且COX-2的表达与K-ras和Mcl-1的表达呈正相关。结论COX-2的表达与K-ras的基因突变和Mcl-1的表达上调有关,在肺癌的分化、进展过程中具有重要作用。 Background and objective Cyclooxygenase-2 (COX-2) is a subtype of rate-limiting enzyme in arachidonic acid metabolism, and it is related with tumorignesis, development and metastasis. In this study, we investigated the expression and clinical significance of COX-2 and its relationship with expression of K-ras and Mcl-1 proteins. Methods The expression of COX-2, K-ras and Mcl-1 were detected in 101 lung cancer tissues and 7 normal lung tissues by immunohistochemical method and image analysis system. Results The overexpression of COX-2 protein was detected in non-small cell lung cancer (P〈0.05), especially in adenocareinoma; There was overexpression of COX-2 in the peripheral type and late stage lung cancer (P〈0.05); There was positive correlation among the COX-2, K-ras and Mcl-l(P〈0.05). Conclusion The expression of COX-2 was closely related with K-ras gene mutation and Mcl-2 upregulation, it played an important role during differentiation and progression of lung cancer.
出处 《中国肺癌杂志》 CAS 2009年第3期216-221,共6页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 环氧化酶-2 K-ras癌基因 髓细胞白血病因子-1 免疫组织化学 图像分析 Lung neoplasms Cyclooxygenase-2 Oncogene K-ras Myeloid Cell Leukemia 1 Immunohistochemistry Image Analysis
  • 相关文献

参考文献15

  • 1周彩存,易祥华,倪健,高文.环氧合酶2在非小细胞肺癌表达的临床意义[J].中华结核和呼吸杂志,2005,28(2):125-127. 被引量:4
  • 2Regina S, Rollin J, Bl e chet C, et al. Tissue factor expression in nonsmall cell tung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. J Thorac Oncol, 2008, 3(7): 489-497.
  • 3Song L, Coppola D, Livingston S, et al. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Cancer Biol Ther, 2005, 4(3): 267-276.
  • 4Travis WD, Brambila E, Muller-Hermelink GK, et al. World Health Organization classification of tumors, pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: LARC Press, 2004. 9-124.
  • 5Tsujii M, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA, 1997, 94(7): 3336-3340.
  • 6Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 1995, 83: 493-501.
  • 7Watkins DN, Lenzo JC, Segal A, et al. Expression and localization of cyclooxygenase isoforms in non-small cell lung cancer. Eur Respir J, 1999, 14(2): 412-418.
  • 8Murata H, Kawano S, Tiuji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.Am J Gastroenterol, 1999, 94(2): 451-455.
  • 9Tsubochi H, Sato N, Hiyama M, et al. Combined analysis of cyclooxy- genase-2 expression with p53 and Ki-67 in non-small cell lung cancer. Ann Thorac Surg, 2006, 82(4): 1198-1204.
  • 10Johnson L, Mercer K, Greenbaum D. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature, 2001, 10(26): 1111-1115.

二级参考文献15

  • 1Niki T, Kohno T, Iba S, et al. Frequent co-localization of COX-2 and laminin-5 gamma 2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol, 2002, 160:1129-1141.
  • 2Achiwa H, Yatabe Y, Hida T, et al. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinoma. Clin Cancer Res, 1999, 5: 1001-1005.
  • 3Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer. Clin Cancer Res,2001, 7: 861-867.
  • 4Sweeney CJ. Why cycooxygenase-2 inhibition plus chemotherapy? Am J Clin Oncol, 2003, 26:S122-S125.
  • 5Altorki NK, Keresztes RS, Port JL, et al. Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. J Clin Oncol, 2003, 21: 2645-2650.
  • 6Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer [J]. Annu Rev Med, 2003,54(1):73-87.
  • 7Ahrendt SA, Decker PA, Alawi EA, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of lung [J]. Cancer, 2001,92(6):1525-1530.
  • 8Porta M, Ayude D, Alguacil J, et al. Exploring environmental causes of altered ras effect: fragmentation plus integration [J]?Mol Carcinog, 2003, 36(2):45-52.
  • 9Osaki T, Oyama T, Gu CD, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-cell lung cancer [J]. J Clin Oncol, 2002, 20(13):2930-2936.
  • 10Ahrendt SA, Yang SC, Wu L, et al. Molecular assessment of lymph nodes in patients with resected stage I non-small lung cancer: presents result of a prospective study [J]. Thorac Cardiovasc Surg, 2002,123(3):466-474.

共引文献5

同被引文献17

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部